Identification of an Individualized Metabolism Prognostic Signature and Related Therapy Regimens in Early Stage Lung Adenocarcinoma
ObjectiveThe choice of adjuvant therapy for early stage lung adenocarcinoma (LUAD) remains controversial. Identifying the metabolism characteristics leading to worse prognosis may have clinical utility in offering adjuvant therapy.MethodsThe gene expression profiles of LUAD were collected from 22 pu...
Main Authors: | Junjie Hu, Huansha Yu, Liangdong Sun, Yilv Yan, Lele Zhang, Gening Jiang, Peng Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.650853/full |
Similar Items
-
PAC-5 Gene Expression Signature for Predicting Prognosis of Patients with Pancreatic Adenocarcinoma
by: Jieun Kim, et al.
Published: (2019-11-01) -
Identification of an eight-gene prognostic signature for lung adenocarcinoma
by: Li S, et al.
Published: (2018-09-01) -
Identification of four differentially methylated genes as prognostic signatures for stage I lung adenocarcinoma
by: Wei-Ming Luo, et al.
Published: (2018-04-01) -
Development of a miRNA-seq based prognostic signature in lung adenocarcinoma
by: Chathura Siriwardhana, et al.
Published: (2019-01-01) -
Identification of a Hypoxia-Associated Signature for Lung Adenocarcinoma
by: Zhuomao Mo, et al.
Published: (2020-06-01)